Health app users, care professionals both see quality of life benefits

The majority of mobile health application users and medical professionals believe those apps are beneficial to their quality of life, according to a survey by Research Now.

Researchers polled 1,000 mobile health app users and 500 medical professionals and found that 96 percent of them said that mobile health apps "improve their quality of life."

Among the app users, 60 percent use them to monitor activity/workouts, 53 percent as motivation to exercise; 49 percent to record calorie intake; and 42 percent to monitor weight loss

The surveyed healthcare professionals indicated the following:

  • 86 percent believe mobile health apps will increase their of their patients' medical conditions;
  • 76 percent believe the apps will help patients with chronic disease management;
  • 61 percent believe the apps will help those who are at a high risk of developing health issues;
  • 55 percent believe the apps could help healthy individuals stay healthy;
  • 48 percent believe the apps could help patients recently discharged from a hospital; and
  • 46 percent believe the apps will improve their relationship with their patients.

Only 16 percent of healthcare professionals reported that they currently use mobile health apps but 46 percent said they plan on using such apps in the next five years.   

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.